Childhood Kidney Diseases

Korean Society of Pediatric Nephrology (대한소아신장학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Features and Prognosis of Henoch-Schönlein Purpura in Children and Adults: A 13-Year Retrospective Study at a Single Centre

  • Jung, Do Young (Department of Pediatrics, Yonsei University Wonju College of Medicine) ;
  • Kwon, Ye Rim (Department of Pediatrics, Yonsei University Wonju College of Medicine) ;
  • Yu, Min Heui (Center of Biomedical Data Science, Yonsei University Wonju College of Medicine) ;
  • Namgoong, Mee Kyung (Department of Pediatrics, Yonsei University Wonju College of Medicine)
  • Received : 2017.08.21
  • Accepted : 2017.09.27
  • Published : 2017.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To investigate differences in clinical features, blood/urinary findings, and prognosis in different age groups of patients with Henoch-$Sch{\ddot{o}}nlein$ purpura (HSP). Methods: A total of 469 patients with HSP were analyzed retrospectively from June 2003 to February 2016. We classified patients into child or adult groups based on their age. Results: The adult group had more patients with anemia (child vs. adult; 7.5% vs. 16.4%), and higher immunoglobulin A (IgA) (30.0% vs. 50.0%) levels, C-reactive protein (34.2% vs. 54.0%) and uric acid (3.1% vs. 12.1%) levels than the child group. The child group was highly positive for Mycoplasma pneumoniae immunoglobulin M (IgM) (34.4%). More patients in the child group presented with high levels of antistreptolysin O (24.7% vs. 2.9%) and high C4 (11.5% vs. 4.2%). Low C3 (1.1% vs. 10.2%) levels, and renal involvement with gross hematuria (8.6% vs. 21.5 %), nonnephrotic proteinuria (1.1% vs. 11.2%), and nephrotic syndrome (1.1% vs. 6.0%) were common in the adult group. Adults also had poorer renal outcomes [persistent hematuria/proteinuria (10.5% vs. 32.8%), and chronic kidney disease (0% vs. 11.2%)] than the child group. Risk factors for renal involvement such as older age and higher level of uric acid were only found in the child group. The risk factors for poor renal outcome were nephrotic syndrome in the child group and gross hematuria in the adult group. Conclusion: In this study, child and adult groups presented with different clinical manifestations of HSP. We found that risk factors for renal involvement included age and high uric acid level in the child group. Moreover, nephrotic syndrome in the child group and gross hematuria in the adult group increased the risk of poor renal outcome.

Keywords

References

  1. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005;90:916-20. https://doi.org/10.1136/adc.2005.074641
  2. Goldstein AR, White RH, Akuse R, Chantler C.Long-term followup of childhood Henoch-Schonlein nephritis. The Lancet 1992;339:280-2. https://doi.org/10.1016/0140-6736(92)91341-5
  3. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schonleinpurpura in adults: outcome and prognostic factors. J Am SocNephrol 2002;13:1271-8.
  4. Ronkainen J, Nuutinen M, Koskimies O.The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study. The Lancet 2002;360:666-70. https://doi.org/10.1016/S0140-6736(02)09835-5
  5. Garcia-Porrua C, Calvino MC, Llorca J, Couselo JM, Gonzalez-Gay MA. Henoch-Schonlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 2002;32:149-56. https://doi.org/10.1053/sarh.2002.33980
  6. Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005;35:143-53. https://doi.org/10.1016/j.semarthrit.2005.08.007
  7. Komatsu, H, Fujimoto, S, Yoshikawa, N, Kitamura, H, Sugiyama, H, Yokoyama H. Clinical manifestations of Henoch-Schonlein purpura nephritis and IgA nephropathy: comparative analysis of data from the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 2016;20:552-60. https://doi.org/10.1007/s10157-015-1177-0
  8. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria For Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 2010;69:798-806. https://doi.org/10.1136/ard.2009.116657
  9. Stanley F. Lo. Reference intervals for laboratory tests and procedures. In:Behrman RE, Kliegman RM, Stanton BF, Geme JW, Schor NF, editors. Nelson Textbook of Pediatrics. 20th ed. Philadephia: Elsevier, 2015: 3464-73.
  10. Kratz A, Pesce MA, Basner RC, Einstein AJ. Laboratory Values of Clinical Importance. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. editors. Harrison's Principles of Internal Medicine, 19ed. New York:McGraw-Hill, 2014:2754-64.
  11. Hung SP, Yang YH, Lin YT, Wang LC, Lee JH, Chiang BL. Clinical manifestations and outcomes of Henoch-Schonlein purpura: comparison between adults and children. Pediatr Neonatol 2009;50:162-8. https://doi.org/10.1016/S1875-9572(09)60056-5
  12. Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, et al. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schonlein purpura. J Korean Med Sci 2014;29:198-203. https://doi.org/10.3346/jkms.2014.29.2.198
  13. Veraldi S, Mancuso R, Rizzitelli G, Gianotti R, Ferrante P. Henoch-Schonlein syndrome associated with human Parvovirus B19 primary infection. Eur J Dermatol 1999;9:232-3.
  14. Saulsbury FT. Henoch-Schonlein Purpura in Children: Report of 100 Patients and Review of the Literature. Medicine 999;78:395-409.
  15. Drago F, Arditi MR, Rebora A. Henoch-Schonlein purpura induced by fluoroquinolones. Br J Dermatol 1994;131:448.
  16. Borras-Blasco J, Enriquez R, Amoros F, Cabezuelo JB, Navarro-Ruiz A, Perez M, et al. Henoch-Schonlein purpura associated with clarithromycin. Case report and review of literature. IntJ Clin Pharmacol Ther 2003;41:213-6. https://doi.org/10.5414/CPP41213
  17. Blanco R, Gonzalez-Gay MA, Ibanez D, Alba C, Perez de Llano LA. Henoch-Schonlein purpura as a clinical presentation of small cell lung cancer. ClinExpRheumatol1997;15:545-7.
  18. Zickerman AM, Allen AC, Talwar V, Olczak SA, Brownlee A, Holland M, et al. IgA myeloma presenting as Henoch-Schonlein purpura with nephritis. Am J Kidney Dis 2000;36:E19.1-5.
  19. Garcias VA, Herr HW. Henoch-Schonlein purpura associated with cancer of prostate. Urology 1982;19:155-8. https://doi.org/10.1016/0090-4295(82)90571-4
  20. Blanco P, Denisi R, Rispal P, Deminiere C, Pellegrin JL, Leng B, et al. Henoch-Schonlein purpura associated with segmental and focal proliferative glomerulonephritis in a patient with Hodgkin's disease. Nephrol Dial Transplant 1999;14:179-80. https://doi.org/10.1093/ndt/14.1.179
  21. Day C, Savage CO, Jones EL, Cockwell P. Henoch-Schonlein nephritis and non-Hodgkin's lymphoma. Nephrol Dial Transplant 2001;16:1080-1. https://doi.org/10.1093/ndt/16.5.1080
  22. Hung SP, Yang YH, Lin YT, Wang LC, Lee JH, Chiang BL. Clinical manifestations and outcomes of Henoch-Schonlein purpura: comparison between adults and children. PediatrNeonatol 2009;50:162-8
  23. Goldstein, Amanda R., et al. Long-term follow-up of childhood Henoch-Schonlein nephritis. Lancet 1992;1;339:280-2. https://doi.org/10.1016/0140-6736(92)91341-5
  24. Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schonlein-Henoch purpura nephritis in children. Pediatr Nephrol 1999;13:816-23. https://doi.org/10.1007/s004670050707
  25. Calvino MC, Llorca J, Garcia-Porrua C, Fernandez-Iglesias JL, and Rodriguez-Ledo P, et al. Henoch-Schonlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine 2001;80:279-90. https://doi.org/10.1097/00005792-200109000-00001
  26. Butani L, Morgenstern BZ. Long-term outcome in children after Henoch-Schonlein purpura nephritis. Clin Pediatr 2007;46:505-11. https://doi.org/10.1177/0009922806298896
  27. Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study. Lancet 2002;360:666-70. https://doi.org/10.1016/S0140-6736(02)09835-5
  28. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schonlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002;13:1271-8. https://doi.org/10.1097/01.ASN.0000013883.99976.22
  29. Rosanna Coppo, Simeone Andrulli, Alessandro Amore, Bruno Gianoglio, Giovanni Conti, Licia Peruzzi, et al. Predictors of Outcome in Henoch-Schonlein Nephritis in Children and Adults. Am J Kidney Dis 2006;47:993-1003. https://doi.org/10.1053/j.ajkd.2006.02.178
  30. Shi Y, Chen W, Jalal D, Li Z, Chen W, Mao H, Yang Q, Johnson RJ, et al. Clinical outcome of hyperuricemia in IgA nephropathy: a retrospective cohort study and randomized controlled trial. Kidney Blood Press Res 2012;35:153-60. https://doi.org/10.1159/000331453
  31. Calvino MC, Llorca J, Garcia-Porrua C, Fernandez-Iglesias JL, Rodriguez- Ledo P, Gonzalez-Gay MA. Henoch-Schonlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine 2001;80:279-90. https://doi.org/10.1097/00005792-200109000-00001
  32. Trygstad CW, Stiehm ER. Elevated serum IgA globulin in anaphylactoid purpura. Pediatrics 1971;47:1023-8.
  33. Davin JC, Ten Berge IJ, Weening JJ. What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis? Kidney Int 2001;59:823-34. https://doi.org/10.1046/j.1523-1755.2001.059003823.x
  34. Motoyama O, Iitaka K. Henoch-Schonleinpurpura with hypocomplementemia in children. PediatrInt 2005;47:39-42.
  35. Lin Q, Min Y, Li Y, Zhu Y, Song X, et al. Henoch-Schonlein purpura with hypocomplementemia. PediatrNephrol 2012;27:801-6.
  36. Kawana S, Nishiyama S.Serum SC5b-9 (terminal complement complex) level, a sensitive indicator of disease activityin patients with Henoch-Schonlein purpura. Dermatology 1992;184:171-6. https://doi.org/10.1159/000247535
  37. Smith GC, Davidson JE, Hughes DA, Holme E, Beattie TJ. Complement activation in Henoch-Schonlein purpura. Pediatr Nephrol 1997;11:477-80. https://doi.org/10.1007/s004670050320
  38. Kuzma-Mroczkowska E, Panczyk-Tomaszewska M, Szmigielska A, Szymanik-Grzelak H, Roszkowska-Blaim M. Mycoplasma pneumoniae as a trigger for Henoch-Schonlein purpura in children. Cent Eur J Immunol 2015;40:489-92.

Cited by

  1. Management of IgA vasculitis nephritis (Henoch-Schonlein purpura nephritis) in Children vol.24, pp.1, 2017, https://doi.org/10.3339/jkspn.2020.24.1.1